arrow
E

Elisabetta Xue

memorial sloan kettering cancer center
H指数:16
被引数:995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression

鼻咽癌(NPC)中分子和免疫景观因生长抑素受体2(<i>SSTR2</i>)表达而异

2026-09-300
OAAI
Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis

重预处理弥漫性大B细胞淋巴瘤患者中loncastuximab tesirine的治疗效果,包括CAR T细胞疗法后的情况:一项Meta分析

Cancer
IF5.1
2026-08-110
PRE
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trial

成熟T或NK淋巴瘤的同种异体造血细胞移植: II期临床试验

2026-04-230
OAAI
It mite not be graft-versus-host disease: frequency and clinical features of Demodex folliculitis after allogeneic hematopoietic cell transplantation

这可能不是移植物抗宿主病:异基因造血细胞移植后蠕形螨毛囊炎的频率和临床特征

2026-04-150
OAAI
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

EZH2表达和活性的基因组与免疫相关性在嗅神经母细胞瘤中的研究

2025-11-010
OAAI
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

癌症临床试验中与FDA药物审批相关的患者入组标准及基线特征(2009–2023)

2025-06-260
OA
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation

供者年龄和供者巨细胞病毒血清状态对亲属供者异基因造血干细胞移植后结局的影响

2025-03-120
PRE
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
2024-09-201
OAAI
Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023)

临床 trials 中 performance status 限制与 US food and drug administration (FDA) 药物审批的关系:一项跨越十年(2014-2023)的横断面研究

2024-09-010
PRE
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
2024-01-061
OAAI
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

异基因造血干细胞移植受者的人类疱疹病毒6特异性T细胞免疫

2023-09-1511
OAAI
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft- versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases
2023-08-011
PRE